CEACAM1
Authors:
Open Access
- 1 October 2014
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 75 (4) , N21-N22
Abstract
The role of the immune response in blood-brain barrier (BBB) breakdown and subsequent secondary tissue injury after ischemic stroke has become of increasing interest.1 The innate immune system plays a role in postischemic inflammatory injury by promoting neutrophil activation, migration, adhesion, and subsequent extravasation during tissue reperfusion. Matrix metalloproteinase-9 (MMP-9) is an inflammatory protein that permanently disrupts extracranial-extracranial junctions of the BBB, provoking leukocyte and plasma protein extravasation and subsequent brain edema. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a known inhibitory coreceptor that serves to maintain the BBB by suppressing deleterious signal transduction.2 To date, the relationship between CEACAM1 and MMP-9 in secondary tissue injury in stroke has not been investigated.Keywords
This publication has 4 references indexed in Scilit:
- Carcinoembryonic Antigen–Related Cell Adhesion Molecule 1 Inhibits MMP-9–Mediated Blood–Brain–Barrier Breakdown in a Mouse Model for Ischemic StrokeCirculation Research, 2013
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat2007
- CEACAM1: contact-dependent control of immunityNature Reviews Immunology, 2006